Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Lotze

Showing results (11-20 of 255) with videos related to

Pageof 26
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
The Adaptome as Biomarker for Assessing Cancer Immunity and ImmunotherapyJian Han, Michael T Lotze
Cancer Immunology, Immunotherapy : CII|January 24, 2004
A primer on cancer immunology and immunotherapyMichael T Lotze, Michael Papamichail
Journal of Medical Virology|May 7, 2020
DC/L-SIGNs of hope in the COVID-19 pandemicAdam Brufsky, Michael T Lotze
Journal of Leukocyte Biology|June 20, 2017
Perpetual change: autophagy, the endothelium, and response to vascular injuryUlka Sachdev, Michael T Lotze
Trends in Immunology|September 12, 2007
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redoxAnna Rubartelli, Michael T Lotze
Journal of Medical Virology|May 28, 2020
Ratcheting down the virulence of SARS-CoV-2 in the COVID-19 pandemicAdam Brufsky, Michael T Lotze
Journal of Immunological Methods|May 24, 2006
Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cellsDavid T Montag, Michael T Lotze
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Addicted to death: invasive cancer and the immune response to unscheduled cell deathHerbert J Zeh, Michael T Lotze
Cancer Gene Therapy|July 24, 2002
Viruses as gene delivery vectors: application to gene function, target validation, and assay developmentMichael T Lotze, Thomas A Kost
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Targeting damage-associated molecular pattern molecules (DAMPs) and DAMP receptors in melanomaBrian A Boone, Michael T Lotze
Pageof 26

Showing results (11-20 of 255) with videos related to

Sort By:
Pageof 26
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
The Adaptome as Biomarker for Assessing Cancer Immunity and ImmunotherapyJian Han, Michael T Lotze
Cancer Immunology, Immunotherapy : CII|January 24, 2004
A primer on cancer immunology and immunotherapyMichael T Lotze, Michael Papamichail
Journal of Medical Virology|May 7, 2020
DC/L-SIGNs of hope in the COVID-19 pandemicAdam Brufsky, Michael T Lotze
Journal of Leukocyte Biology|June 20, 2017
Perpetual change: autophagy, the endothelium, and response to vascular injuryUlka Sachdev, Michael T Lotze
Trends in Immunology|September 12, 2007
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redoxAnna Rubartelli, Michael T Lotze
Journal of Medical Virology|May 28, 2020
Ratcheting down the virulence of SARS-CoV-2 in the COVID-19 pandemicAdam Brufsky, Michael T Lotze
Journal of Immunological Methods|May 24, 2006
Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cellsDavid T Montag, Michael T Lotze
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Addicted to death: invasive cancer and the immune response to unscheduled cell deathHerbert J Zeh, Michael T Lotze
Cancer Gene Therapy|July 24, 2002
Viruses as gene delivery vectors: application to gene function, target validation, and assay developmentMichael T Lotze, Thomas A Kost
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Targeting damage-associated molecular pattern molecules (DAMPs) and DAMP receptors in melanomaBrian A Boone, Michael T Lotze
Pageof 26